Xinjun Liang
Hubei Cancer Hospital(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Gut microbiota and health, Gastric Cancer Management and Outcomes, Nanoplatforms for cancer theranostics, Extracellular vesicles in disease, Ferroptosis and cancer prognosis
Most-Cited Works
- → Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial(2023)555 cited
- → Male‐Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development(2023)47 cited
- → Expansion of Colorectal Cancer Biomarkers Based on Gut Bacteria and Viruses(2022)36 cited
- → Black rice diet alleviates colorectal cancer development through modulating tryptophan metabolism and activating AHR pathway(2024)31 cited
- → circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis(2022)27 cited
- → Manganese Dioxide/Gold-based Active Tumor Targeting Nanoprobes for Enhancing Photodynamic and Low-Temperature-Photothermal Combination Therapy in Lung Cancer(2023)18 cited
- → Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer(2024)7 cited
- → First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study(2025)4 cited
- → Efficacy and safety of IBI363 monotherapy or in combination with bevacizumab in patients with advanced colorectal cancer.(2025)3 cited
- → The role of post-translational modifications of cGAS in γδ T cells(2024)3 cited